These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8848422)

  • 1. [The role of genetically determined acetylation of drugs and xenobiotics in pathogenesis of neoplastic diseases].
    Niewiński P; Orzechowska-Juzwenko K
    Postepy Hig Med Dosw; 1996; 50(2):131-43. PubMed ID: 8848422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of genetically determined oxidation of drugs and xenobiotics in pathogenesis of neoplastic diseases].
    Niewiński P; Orzechowska-Juzwenko K
    Postepy Hig Med Dosw; 1996; 50(4):321-32. PubMed ID: 9019742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of genetically determined acetylation of drugs and xenobiotics in pathogenesis of neoplasms].
    Niewiński P; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 1997 Jan; 2(9):231-5. PubMed ID: 10907039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic significance of determined oxidation of drugs and xenobiotics in the pathogenesis of neoplastic diseases].
    Niewiński P; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 1997 Jan; 2(7):71-5. PubMed ID: 9296908
    [No Abstract]   [Full Text] [Related]  

  • 5. The biochemistry of drug metabolism--an introduction: part 4. reactions of conjugation and their enzymes.
    Testa B; Krämer SD
    Chem Biodivers; 2008 Nov; 5(11):2171-336. PubMed ID: 19035562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin: major target organ of allergic reactions to small molecular weight compounds.
    Merk HF; Baron JM; Neis MM; Obrigkeit DH; Karlberg AT
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):313-7. PubMed ID: 17462686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic and toxicologic results in genetic polymorphisms (review)].
    Kohút A; Kalina I
    Cesk Fysiol; 1998 Dec; 47(4):172-84. PubMed ID: 10535175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report].
    Milejski P; Orzechowska-Juzwenko K; Niewiński P; Hurkacz M; Czarnik-Matusewicz H; Leszek J; Rudzik J; Grotthus B
    Psychiatr Pol; 2007; 41(2):261-9. PubMed ID: 17598435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining protein modeling and 6D-QSAR. Simulating the binding of structurally diverse ligands to the estrogen receptor.
    Vedani A; Dobler M; Lill MA
    J Med Chem; 2005 Jun; 48(11):3700-3. PubMed ID: 15916421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polymorphism of acetylation and oxidation phenotypes and the risk of neoplasms--pharmacogenetic approach to the epidemiology of neoplasms].
    Mrozikiewicz PM
    Postepy Hig Med Dosw; 1992; 46(5):531-6. PubMed ID: 1298959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The importance of the acetylation in the dosage some drugs (author's transl)].
    Skretkiewicz J
    Przegl Lek; 1981; 38(2):307-9. PubMed ID: 7244287
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxicogenomics -- a novel opportunity to probe lupus susceptibility and pathogenesis.
    Tsay GJ; Zouali M
    Int Immunopharmacol; 2008 Oct; 8(10):1330-7. PubMed ID: 18687295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphic NATs and cancer predisposition.
    Hirvonen A
    IARC Sci Publ; 1999; (148):251-70. PubMed ID: 10493262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetically determined abnormal reactions to drugs].
    Prandota J; Iwańczak F; Panków-Prandota L
    Pediatr Pol; 1980 Apr; 55(4):525-30. PubMed ID: 6997825
    [No Abstract]   [Full Text] [Related]  

  • 15. [Genetic polymorphisms of oxidation and acetylation in cancers of digestive system].
    Barańska M; Skretkowicz J
    Pol Merkur Lekarski; 2009 Feb; 26(152):145-7. PubMed ID: 19388522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evolution of industrial toxicology toward vanishing doses and the human genome].
    Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
    Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolism of drugs. II. The factors influencing metabolic reactions].
    Dyderski S; Grzymisławski M
    Pol Merkur Lekarski; 2005 Apr; 18(106):453-6. PubMed ID: 16161933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochromes P450, drugs, and diseases.
    Guengerich FP
    Mol Interv; 2003 Jun; 3(4):194-204. PubMed ID: 14993447
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolism of drugs. I. Basic metabolic reactions].
    Dyderski S; Grzymisławski M
    Pol Merkur Lekarski; 2005 Apr; 18(106):446-52. PubMed ID: 16161932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The biochemical basis of toxic actions of drugs and other xenobiotics].
    Nuhn P
    Pharm Unserer Zeit; 1993 Jul; 22(3):119-33. PubMed ID: 8367516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.